Impact of the US Preventive Services Task Force Grade D Recommendation: Assessment of Evaluations for Elevated Prostate-specific Antigen and Prostate Biopsies in a Large Urology Group Practice Following Statement Revision

On October 7, 2011, the United States Preventive Services Task Force (USPSTF) released their evidence statement and grade D recommendation against prostate-specific antigen (PSA)-based prostate cancer screening.

Using a time series design, we assessed the effect of this recommendation upon evaluations for elevated PSA levels and prostate biopsies in our large urology group practice. We found that, despite a 24. 1% increase in total visits, the 32 urologists in our practice completed 16. 4% fewer evaluations for elevated PSA levels (317 fewer evaluations per month; P = . 017) and 21. 4% fewer prostate biopsies (42 fewer biopsies per month; P = . 001) in the 2 years following the USPSTF grade D recommendation.

Reviews in urology. 2015 [Epub]

Kathleen F McGinley, Gregory C McMahon, Gordon A Brown

Department of Urology, Rowan University School of Osteopathic Medicine, Stratford, NJ.

PubMed      Full Text Article

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe